DUX4 and facioscapulohumeral muscular dystrophy: The current model of FSHD pathogenesis emerged from studies undertaken over the last two decades, but the recognition of DUX4 as a causal factor in FSHD is relatively recent, and has prompted efforts to develop DUX4-expressing animal models using transgenics or viral vectors [8,18–20].